Transplantation Grants

Excellence in Blood and Marrow Transplantation Award

Award: Monetary award of $1000 and a plaque.

Purpose: To recognize and support excellence in nurses engaged in blood and marrow transplantation

Nominee's Eligibility Criteria:
The candidate must meet the following criteria:

* Be a registered professional nurse and an active ONS member
* Have at least two years of oncology nursing experience
* Be a recognized expert in the field of blood and marrow transplantation (e.g., through publications, presentations, research, and peer review)
* Made a significant contribution to one or more of the following related to blood and marrow transplantation: professional/patient education, clinical practice, and/or nursing research
* Serves as a role model for other nurses.

Criteria:
The scoring criteria for judging this nomination is as follows:

* ONS involvement: Participation should include involvement at the local or national level.
o Includes membership on committees, holding office, or task force participation.
* Recognized expert in the field of blood and marrow transplantation, contributing to the development of blood and marrow transplantation.
o Includes articles in newsletters, journals, reports, video, multimedia, computer assisted instruction, chapters in books (do not include research here, include research in last criteria point).
* Significant contribution to the following areas:
o Professional/patient education related to blood and marrow transplantation
o Presentations
o Examples in letters of role modeling
o Specific educational interventions
o Program development
o Support groups
o Adjunct faculty to preceptor for students
o Community outreach
* Clinical practice related to blood and marrow transplantation:
o Theoretical concepts used
o Nursing process used
o Professional development of self and others
o Multidisciplinary collaboration
o Quality assurance
o Ethical decision-making used
o Reviews/applies nursing research
o Blood and marrow transplantation research

Application deadline: August 16, 2010, 5pm (ET).

For more information on any of the ONS awards, contact ONS at customer.service@ons.org. Both nominees and nominators will be notified once an application is received.

Oncology Nursing Society
125 Enterprise Drive Pittsburgh, PA15275
866-257-4ONS (866-257-4667)
412-859-6100
877-369-5497 (toll free fax)
412-859-6162 (fax)

2011 Thomas E. Starzl Prize in Surgery and Immunology

The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2011 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation. The prize consists of a crystal award, an honorarium of $15,000, and travel expenses to the University of Pittsburgh School of Medicine in the spring of 2011 to formally receive the award and to present the Thomas E. Starzl Prize in Surgery and Immunology lecture. Over a two-day period, the winner will also participate in related activities and meet informally with faculty, postdoctoral fellows and students.

Nomination deadline: May 3, 2010

The Thomas E. Starzl Prize in Surgery and Immunology, previously known as the Annual Thomas E. Starzl Lectureship, was established in 1996 by the Department of Surgery and subsequently endowed by Fujisawa Healthcare, Inc. (currently Astellas Pharma, Inc.) to honor the clinical and scientific contributions of Dr. Thomas E. Starzl. Outstanding national and international leaders who have made significant contributions to the fields of organ transplantation and immunology are invited to the University of Pittsburgh to present their work and receive the prize.
Dr. Starzl joined the University of Pittsburgh in 1981 to direct the Pittsburgh Transplantation Institute, which in 1996 was renamed the Thomas E. Starzl Transplantation Institute. He now holds the position of Professor of Surgery and Distinguished Service Professor at the University of Pittsburgh.

Dr. Starzl was the first to transplant kidneys in humans with consistent success, perform liver transplantation, and successfully transplant human intestines. He introduced four commonly used immunosuppressive drugs (prednisone, ALG, cyclophosphamide, and tacrolimus) for clinical transplantation. The discovery in 1992 by Dr. Starzl and colleagues of donor-derived leukocytes in the tissues of long-term functioning organ transplant recipients unmasked a fundamental principle of transplantation tolerance. Dr. Starzl’s seminal contributions to the field of organ transplantation and immunology have been recognized around the globe. His most recent distinctions include the 2004 National Medal of Science, the nation’s highest scientific honor, the 2009 Department of Veterans Affairs Diamond Award for Lifetime Achievement in the Field of Transplantation Medicine, and the 2009 Institute of Medicine Gustav O. Lienhard Award.

Nomination Procedure
Please submit the following information electronically to starzlprize@upmc.edu:

1. a completed nomination form (available on http://stiresearch.health.pitt.edu),
2. a letter of nomination with a detailed description of the research accomplishments that qualify the nominee for this award, and
3. a copy of the nominee’s current curriculum vitae.

The deadline for receipt of all nomination materials is May 3, 2010.

Questions concerning the Thomas E. Starzl Prize in Surgery and Immunology or the nomination process may be referred to 412-383-8884 or starzlprize@upmc.edu.

Thomas E. Starzl Postdoctoral Fellowship in Transplantation Biology

The Thomas E. Starzl Postdoctoral Fellowship in Transplantation Biology has been established to train outstanding national or international M.D., Ph.D. or M.D./Ph.D. postdoctoral fellows who exhibit potential to develop into highly successful independent investigators and likely to remain in transplantation research. The purpose of this two-year fellowship is (1) to foster the training of research fellows with the potential to develop into successful independent investigators and (2) to foster, through training research fellows, transplant-related research that is of high merit.

Additional fellowship information, application instructions, and application forms will be available in the summer of 2010. Inquiries concerning the application process should be made to stiresearch@pitt.edu.

Application deadline is December 1, 2010 with a beginning start date of July 1, 2011.

Society for Hematology and Stem Cells Travel Grants to ISEH 2010 Meeting

Date: 15 - 18 September, 2010

Location: Melbourne Convention & Exhibition Centre, Melbourne Australia (www.mcec.com.au/)

Through the generous support of the State government of Victoria we are able to offer up to 200 travel grants for PhD students and post-doctoral delegates as follows:

Delegates traveling from Europe AUD$2000
Delegates traveling from the USA AUD$1500
Delegates traveling from Asia AUD$1200
Delegates traveling from New Zealand or within Australia AUD$300

Applications need to be submitted with your abstract and will be assessed based on the abstract rankings. Travel award applicants must also include a letter from their Mentor/Supervisor with their abstract submission requesting travel support and identifying need. *You must be an ISEH member to apply for a travel grant.

Key Dates:

* Registration /Abstract Submission Open; March 1, 2010
* Abstract Submissions Close: May 1, 2010
* Travel Grant Requests Close: May 1, 2010
* Early Bird Registration Closes: June 1, 2010

The Society for Hematology and Stem Cells (ISEH) was established in 1950 by a group of scientists who sought to create a forum for the presentation and discussion of pre-clinical data in experimental hematology. ISEH continues to be dedicated to the promotion of the scientific knowledge and clinical application of basic hematologic and immunologic disorders through research, publications, and scientific programs. Incorporated in 1972 in the USA, the Society has over 800 active members from 40 countries around the world. Its annual scientific meeting attracts more than 500 participants over 4 days and, together with its official monthly journal Experimental Hematology, provides essential delivery of quality education, training programs, discussion forums, as well as promotes basic research.

Knowledge
Offering comprehensive programs and publications in training and education, ISEH membership provides the tools for expansive understanding and cutting-edge methodologies from around the globe.

Innovation
Providing the latest scientific information, ISEH members are at the forefront of advances in experimental hematology including:

* Progenitor cells, hematopoiesis, growth factors and cytokines
* Immunology
* Mechanisms of hematologic malignancies (leukemias, lymphomas, myelomas)
* Oncology
* Oncogenes
* Stem Cell niches
* Cancer stem cells
* Gene profiling (microarray chips) and protein chips
* Stem cell biology and transplantation (bone marrow, peripheral blood, cord blood)
* Cellular therapy
* Gene therapy
* Hematopoietic microenvironment

For more information on how to apply for these grants contact ISEH@marqueemarketing.com.au

ISEH
401 N. Michigan Ave, Ste 2400
Chicago, IL 60611 USA
Phone: (+1/202) 367-1183
Fax: (+1/202) 367-2183
E-mail: info@iseh.org

Diabetes Research and Wellness Foundation Research Grants and Educational Grants

In line with the charity’s mission of assisting in the relief of people with diabetes, DRWF is offering financial support for a selected number of proposals and projects connected with diabetes research. The maximum available for each project is $50,000 per year for a maximum of two years.

We offer Research Grants and Educational Grants.

DRWF accepts research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. The maximum support of these grants is up to $50,000 per year for up to 2 years. If the proposed research is within an area of primary interest and is judged as having high scientific merit by the Foundation’s advisors, the Board of Directors may make special grant awards that exceed the stated maximum. Currently, the Foundation’s area of primary interest and focus are islet cell transplantation, macrovascular disease & neuropathy. All other research proposals will not be reviewed.

The deadlines for applications are June 30th and December 30th for each year. All proposals, requests, and reports should be mailed or emailed to the following address:

Diabetes Research and Wellness Foundation

Attn: Executive Director

5151 Wisconsin Avenue, NW

Suite 420

Washington, D.C. 20016

E-mail: diabeteswellness@diabeteswellness.net